The MycoResin™ Biotechnology Platform relies on carefully selected microbial strains capable of interacting with Aquilaria trees to stimulate controlled resin biosynthesis.
The Microbial Strain Selection & Screening Protocols form a critical component of the research program, ensuring that only compatible, stable, and biologically effective microorganisms are incorporated into the BarIno® fungal consortium system.
These protocols combine microbial ecology, plant physiology, and biotechnology screening methods to identify strains that can safely and effectively activate the tree’s natural defense and secondary metabolite pathways.
Microbial Source Identification
Candidate microbial strains are initially sourced from environments associated with agarwood-producing trees, including:
- endophytic fungi residing within plant tissues
- rhizospheric microbes present in root-associated soil ecosystems
- microbial communities associated with naturally resinous Aquilaria trees.
These environments often host microorganisms that play roles in plant signaling, stress response, and metabolic activation.
Isolation and Culture Development
Microbial isolates undergo controlled laboratory cultivation to establish stable cultures for evaluation.
Key objectives during this phase include:
- obtaining pure microbial isolates
- maintaining culture stability
- preserving strain viability for repeated testing.
Culture collections form the foundation of the MycoResin™ microbial library, which supports ongoing research and technology refinement.
Host Compatibility Screening
Selected strains are tested for compatibility with Aquilaria species to ensure safe biological interaction.
Screening criteria include:
- non-pathogenic colonization behavior
- absence of harmful tissue degradation
- stable interaction with plant vascular tissues
- minimal adverse effects on tree health.
Only strains demonstrating balanced interaction with the host plant proceed to further evaluation.
Functional Screening for Resin Induction Potential
Compatible strains are evaluated for their potential to stimulate biological processes associated with agarwood formation.
Indicators may include:
- activation of plant defense signaling
- stimulation of phenolic and terpenoid pathways
- induction of localized wood tissue responses
- early-stage resin development indicators.
This screening identifies strains capable of contributing to controlled resin biosynthesis.
Consortium Compatibility Testing
Because BarIno® technology utilizes multi-strain microbial consortia, selected microorganisms must also be tested for compatibility with each other.
Evaluation criteria include:
- cooperative microbial interactions
- absence of antagonistic effects
- stable coexistence within the host environment
- complementary biological functions.
This ensures that microbial combinations work together to produce consistent biological signaling outcomes.
Field Adaptation Assessment
Strains selected through laboratory screening are further evaluated for field performance characteristics, including:
- environmental tolerance
- colonization stability in plantation conditions
- reproducibility across different tree cohorts.
This stage ensures that microbial candidates remain effective when transitioning from controlled laboratory environments to real plantation ecosystems.
Integration into BarIno® Sequential Inoculation
Microbial strains that pass the selection and screening stages are incorporated into the BarIno® Sequential Inoculation Technology, where they contribute to specific biological phases:
- Priming Phase
- Induction Phase
- Amplification Phase
- Densification Phase
- Maturation Phase
Each phase may involve distinct microbial signaling roles, allowing resin formation to develop progressively through controlled biological activation.
Strategic Importance
The microbial strain selection process ensures that the MycoResin™ platform operates as a scientifically grounded biotechnology system, rather than relying on uncontrolled or opportunistic microbial infection.
Through rigorous screening and evaluation, Crown MycoResin Biotech Inc. aims to build a robust microbial technology foundation capable of supporting predictable agarwood resin production at plantation scale.